Skip to content
← Full study record

NCT01209325 · FLOW

Participant flow

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males · Source last updated 2020-08-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Gardasil (quadrivalent HPV types 6, 11, 16, 18) vaccination at weeks 0, 8, 24. quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine laboratory biomarker analysis
    id
    FG000
    title
    Vaccination
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        24
      type
      Lost to Follow-up
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Adverse Event
    3. reasons
      1. group Id
        FG000
        num Subjects
        3
      type
      Relocated
    4. reasons
      1. group Id
        FG000
        num Subjects
        8
      type
      Refusal after starting therapy
    5. reasons
      1. group Id
        FG000
        num Subjects
        4
      type
      Protocol Violation
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Refusal prior to therapy
    7. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Incarceration
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        149
      comment
      Enrolled
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        145
      type
      Eligible
    3. achievements
      1. group Id
        FG000
        num Subjects
        144
      type
      Received First Vaccine Injection
    4. achievements
      1. group Id
        FG000
        num Subjects
        141
      type
      Received Second Vaccine Injection
    5. achievements
      1. group Id
        FG000
        num Subjects
        138
      type
      Received Third Vaccine Infjection
    6. achievements
      1. group Id
        FG000
        num Subjects
        124
      type
      Returned After Week 28
    7. achievements
      1. group Id
        FG000
        num Subjects
        106
      type
      COMPLETED
    8. achievements
      1. group Id
        FG000
        num Subjects
        43
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Gardasil (quadrivalent HPV types 6, 11, 16, 18) vaccination at weeks 0, 8, 24. quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine laboratory biomarker analysis
    id
    FG000
    title
    Vaccination
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        24
      type
      Lost to Follow-up
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Adverse Event
    3. reasons
      1. group Id
        FG000
        num Subjects
        3
      type
      Relocated
    4. reasons
      1. group Id
        FG000
        num Subjects
        8
      type
      Refusal after starting therapy
    5. reasons
      1. group Id
        FG000
        num Subjects
        4
      type
      Protocol Violation
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Refusal prior to therapy
    7. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Incarceration
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        149
      comment
      Enrolled
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        145
      type
      Eligible
    3. achievements
      1. group Id
        FG000
        num Subjects
        144
      type
      Received First Vaccine Injection
    4. achievements
      1. group Id
        FG000
        num Subjects
        141
      type
      Received Second Vaccine Injection
    5. achievements
      1. group Id
        FG000
        num Subjects
        138
      type
      Received Third Vaccine Infjection
    6. achievements
      1. group Id
        FG000
        num Subjects
        124
      type
      Returned After Week 28
    7. achievements
      1. group Id
        FG000
        num Subjects
        106
      type
      COMPLETED
    8. achievements
      1. group Id
        FG000
        num Subjects
        43
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice